Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ablaza, S. G. G.
Right arrow Articles by Nichols, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ablaza, S. G. G.
Right arrow Articles by Nichols, H. T.
(Chest. 1969;55:25-31.)
© 1969 American College of Chest Physicians

Calf Aortic Valve Heterograft Replacement for Aortic Valvular Disease

Sariel G. G. Ablaza M.D., F.C.C.P.1; Gumersindo Blanco M.D.1; Vladir Maranhao M.D., F.C.C.P.1; Sing San Yang M.D.1; Dryden P. Morse M.D., F.C.C.P.1; and Henry T. Nichols M.D., F.C.C.P.1

1 Department of Thoracic Surgery and the Department of Cardiology, Deborah Hospital, Browns Mills, New Jersey 08015

The calf aortic valve heterograft was used to replace the damaged aortic valves in 15 patients.There were two deaths which occurred in the immediate postoperative period. The first seven of the 13 surviving patients were studied six months postoperatively. Results showed that the heterograft valves were working effectively. There was no systolic pressure gradient acrossthe new valve. Clinical competence of the valves has been confirmed by retrograde aortograms. Heart size has decreased in all cases. All the patients have shown marked improvement. It is obviously too short a time to draw any definite conclusions regarding the eventual fate of the implanted heterograft. However, our early clinical and laboratory results have shown that the calfaortic valve heterograft placed in the subcoronary position functions effectively and is well tolerated by the human host. This is most encouraging and it is felt that in view of these results further clinical application of this technique is warranted.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American College of Chest Physicians.